Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,515.59
1,387.17
1,413.51
1,281.18
1,137.40
942.46
817.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,515.59
1,387.17
1,413.51
1,281.18
1,137.40
942.46
817.55
Raw Material Cost
0.00
567.21
532.23
437.36
326.26
265.00
254.27
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
125.17
121.36
99.18
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.29
0.12
0.16
0.17
0.05
0.04
Selling and Distribution Expenses
0.00
532.51
577.52
585.68
580.40
458.75
392.65
Other Expenses
0.00
2.39
-2.66
-1.92
6.75
6.19
4.36
Total Expenditure (Excl Depreciation)
0.00
1,249.03
1,204.66
1,103.16
974.30
785.69
690.53
Operating Profit (PBDIT) excl Other Income
1515.6
138.1
208.9
178
163.1
156.8
127
Other Income
1,270.46
48.30
37.55
32.91
29.15
15.00
7.97
Operating Profit (PBDIT)
1,515.59
252.83
302.64
248.90
219.19
194.11
153.87
Interest
0.00
0.29
0.12
0.16
0.17
0.05
0.04
Exceptional Items
0.00
0.00
-5.27
0.00
-2.15
0.09
0.01
Gross Profit (PBDT)
0.00
819.96
881.28
843.82
811.14
677.45
563.29
Depreciation
0.00
72.12
62.32
49.02
34.28
29.67
26.19
Profit Before Tax
245.55
180.42
234.92
199.72
182.59
164.48
127.65
Tax
0.00
22.92
36.84
21.57
19.27
19.45
11.64
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
241.47
164.32
211.32
182.80
160.76
145.03
116.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
241.47
164.32
211.32
182.80
160.76
145.03
116.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
-25.56
-18.28
-9.42
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
241.47
138.76
193.04
173.39
160.76
145.03
116.01
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
1.0
1.0
1.0
1.0
0.0
0.0
Reserves
2,045.87
1,803.41
1,723.51
1,596.61
1,479.47
663.05
553.17
Earnings per share (EPS)
0.0
1.25
1.61
1.39
1.22
1.1
0.88
Diluted Earnings per share
0.0
1.25
1.61
1.39
1.22
1.1
0.88
Operating Profit Margin (Excl OI)
16.17%
9.55%
14.34%
13.03%
13.69%
15.86%
14.64%
Gross Profit Margin
16.2%
18.21%
21.03%
19.42%
19.07%
20.6%
18.82%
PAT Margin
15.93%
11.85%
14.95%
14.27%
14.13%
15.39%
14.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 9.26% vs -1.86% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 73.99% vs -28.08% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 19.85% vs -22.86% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -100.00% vs 200.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Hunan Warrant Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,515.59
0
1,515.59
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,515.59
0
1,515.59
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
0.00
0.00
0.00
Total Expenditure (Excl Depreciation)
0.00
0
0.00
Operating Profit (PBDIT) excl Other Income
1,515.59
0.00
1,515.59
Other Income
1,270.46
0
1,270.46
Operating Profit (PBDIT)
1,515.59
0
1,515.59
Interest
0.00
0
0.00
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
0.00
0
0.00
Depreciation
0.00
0
0.00
Profit Before Tax
245.55
0
245.55
Tax
0.00
0
0.00
Provisions and contingencies
0
0
0.00
Profit After Tax
241.47
0
241.47
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
241.47
0
241.47
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
241.47
0
241.47
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
2,045.87
0
2,045.87
Earnings per share (EPS)
0.00
0
0.00
Diluted Earnings per share
0.00
0
0.00
Operating Profit Margin (Excl OI)
16.17%
0%
0.00
16.17%
Gross Profit Margin
16.20%
0%
0.00
16.20%
PAT Margin
15.93%
0%
0.00
15.93%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 151.56 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 9.26% vs -1.86% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 24.15 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 73.99% vs -28.08% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.51 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 19.85% vs -22.86% in Dec 2024
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.17%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






